Diagnos Laboratorium Utama PT Tbk
IDX:DGNS
Cash Flow Statement
Cash Flow Statement
Diagnos Laboratorium Utama PT Tbk
| Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||
| Cash Taxes Paid |
(4 549)
|
(4 549)
|
(6 955)
|
(7 622)
|
(18 274)
|
(19 212)
|
(16 185)
|
(16 425)
|
(19 413)
|
(19 662)
|
(20 082)
|
(19 162)
|
(3 317)
|
(2 140)
|
(10)
|
47
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(346)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(550)
|
(422)
|
(2 614)
|
(369)
|
(1 465)
|
(2 438)
|
|
| Change in Working Capital |
(15 661)
|
(15 661)
|
(21 306)
|
(33 158)
|
(39 889)
|
(50 249)
|
(50 430)
|
(50 533)
|
(52 630)
|
(59 170)
|
(60 454)
|
(60 156)
|
(66 671)
|
(61 624)
|
(62 740)
|
(62 877)
|
(58 215)
|
(62 264)
|
(3 236)
|
(864)
|
(16 648)
|
|
| Cash from Operating Activities |
6 393
N/A
|
6 393
N/A
|
26 228
+310%
|
36 396
+39%
|
21 947
-40%
|
21 027
-4%
|
58 875
+180%
|
47 997
-18%
|
76 987
+60%
|
50 899
-34%
|
(6 016)
N/A
|
1 342
N/A
|
(13 958)
N/A
|
19 500
N/A
|
13 184
-32%
|
14 423
+9%
|
18 375
+27%
|
27 299
+49%
|
(8 020)
N/A
|
(10 375)
-29%
|
(6 783)
+35%
|
|
| Investing Cash Flow | ||||||||||||||||||||||
| Capital Expenditures |
(50)
|
(50)
|
(5 864)
|
(17 212)
|
(20 027)
|
(31 584)
|
(67 841)
|
(62 016)
|
(77 706)
|
(67 063)
|
(34 853)
|
(41 304)
|
(30 814)
|
(39 777)
|
(38 532)
|
(37 319)
|
(34 744)
|
(44 298)
|
8 957
|
11 378
|
7 942
|
|
| Other Items |
(16 966)
|
(16 966)
|
28 138
|
28 125
|
18 596
|
18 596
|
(7 727)
|
10 133
|
(14 690)
|
10 733
|
17 303
|
(4 192)
|
20 631
|
(4 792)
|
(3 856)
|
10
|
127
|
117
|
8
|
(6)
|
(6)
|
|
| Cash from Investing Activities |
(17 016)
N/A
|
(17 016)
N/A
|
22 274
N/A
|
10 914
-51%
|
(1 430)
N/A
|
(12 987)
-808%
|
(75 568)
-482%
|
(51 883)
+31%
|
(92 396)
-78%
|
(56 330)
+39%
|
(17 550)
+69%
|
(45 495)
-159%
|
(10 182)
+78%
|
(44 568)
-338%
|
(42 389)
+5%
|
(37 309)
+12%
|
(34 617)
+7%
|
(44 181)
-28%
|
8 965
N/A
|
11 372
+27%
|
7 936
-30%
|
|
| Financing Cash Flow | ||||||||||||||||||||||
| Net Issuance of Common Stock |
24 750
|
24 750
|
0
|
49 478
|
49 478
|
49 478
|
49 478
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
(4 898)
|
(4 898)
|
(2 933)
|
(2 709)
|
(2 506)
|
641
|
(4 900)
|
(5 770)
|
(1 488)
|
(5 403)
|
6 857
|
10 906
|
5 748
|
16 415
|
11 439
|
7 441
|
11 284
|
10 846
|
3 853
|
267
|
136
|
|
| Cash Paid for Dividends |
0
|
0
|
0
|
0
|
0
|
(6 000)
|
(6 000)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
0
|
0
|
(30 424)
|
(30 809)
|
(25 843)
|
(25 843)
|
6 296
|
5 233
|
1 715
|
1 715
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
19 852
N/A
|
19 852
N/A
|
(33 358)
N/A
|
15 960
N/A
|
21 129
+32%
|
18 276
-14%
|
44 874
+146%
|
(6 538)
N/A
|
(5 773)
+12%
|
(3 688)
+36%
|
6 857
N/A
|
12 354
+80%
|
5 748
-53%
|
16 415
+186%
|
11 439
-30%
|
7 441
-35%
|
11 284
+52%
|
10 846
-4%
|
3 853
-64%
|
267
-93%
|
136
-49%
|
|
| Change in Cash | ||||||||||||||||||||||
| Net Change in Cash |
9 229
N/A
|
9 229
N/A
|
15 145
+64%
|
63 270
+318%
|
41 646
-34%
|
26 315
-37%
|
28 182
+7%
|
(10 424)
N/A
|
(21 182)
-103%
|
(9 118)
+57%
|
(16 709)
-83%
|
(31 799)
-90%
|
(18 392)
+42%
|
(8 653)
+53%
|
(17 766)
-105%
|
(15 444)
+13%
|
(4 958)
+68%
|
(6 036)
-22%
|
4 799
N/A
|
1 265
-74%
|
1 288
+2%
|
|
| Free Cash Flow | ||||||||||||||||||||||
| Free Cash Flow |
6 343
N/A
|
6 343
N/A
|
20 365
+221%
|
19 185
-6%
|
1 921
-90%
|
(10 557)
N/A
|
(8 966)
+15%
|
(14 019)
-56%
|
(719)
+95%
|
(16 163)
-2 148%
|
(40 869)
-153%
|
(39 962)
+2%
|
(44 772)
-12%
|
(20 277)
+55%
|
(25 349)
-25%
|
(22 896)
+10%
|
(16 369)
+29%
|
(16 999)
-4%
|
937
N/A
|
1 004
+7%
|
1 159
+15%
|
|